Literature DB >> 19188697

Telomere length maintenance--an ALTernative mechanism.

N J Royle1, J Foxon, J N Jeyapalan, A Mendez-Bermudez, C L Novo, J Williams, V E Cotton.   

Abstract

The Alternative Lengthening of Telomeres (ALT) mechanism is utilised by approximately 10% of human tumours and a higher proportion of some types of sarcomas. ALT+ cell lines and tumours show heterogeneous telomere length, extra-chromosomal circular and linear telomeric DNA, ALT associated promyelocytic bodies (APBs), a high frequency of post-replication exchanges in telomeres (designated as telomere-sister chromatid exchanges, T-SCE) and high instability at a GC-rich minisatellite, MS32 (D1S8). It is clear that there is a link between the minisatellite instability and the mechanism that underpins ALT, however currently the nature of this relationship is uncertain. Single molecule analysis of telomeric DNA from ALT+ cell lines and tumours has revealed complex telomere mutations that have not been seen in cell lines or tumours that express telomerase. These complex telomere mutations cannot be explained by T-SCE but must arise by another inter-molecular process. The break-induced replication (BIR) model that may explain the observed high frequency of T-SCE and the presence of complex telomere mutations is reviewed. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188697     DOI: 10.1159/000167814

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  13 in total

1.  Roles of heterochromatin and telomere proteins in regulation of fission yeast telomere recombination and telomerase recruitment.

Authors:  Lyne Khair; Lakxmi Subramanian; Bettina A Moser; Toru M Nakamura
Journal:  J Biol Chem       Date:  2009-12-29       Impact factor: 5.157

2.  CpG-island promoters drive transcription of human telomeres.

Authors:  Solomon G Nergadze; Benjamin O Farnung; Harry Wischnewski; Lela Khoriauli; Valerio Vitelli; Raghav Chawla; Elena Giulotto; Claus M Azzalin
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

3.  Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.

Authors:  Christopher M Heaphy; Andrea P Subhawong; Seung-Mo Hong; Michael G Goggins; Elizabeth A Montgomery; Edward Gabrielson; George J Netto; Jonathan I Epstein; Tamara L Lotan; William H Westra; Ie-Ming Shih; Christine A Iacobuzio-Donahue; Anirban Maitra; Qing K Li; Charles G Eberhart; Janis M Taube; Dinesh Rakheja; Robert J Kurman; T C Wu; Richard B Roden; Pedram Argani; Angelo M De Marzo; Luigi Terracciano; Michael Torbenson; Alan K Meeker
Journal:  Am J Pathol       Date:  2011-09-01       Impact factor: 4.307

4.  Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.

Authors:  Jau-Yu Liau; Jen-Chieh Lee; Jia-Huei Tsai; Ching-Yao Yang; Tsung-Lin Liu; Zhi-Long Ke; Hung-Han Hsu; Yung-Ming Jeng
Journal:  Mod Pathol       Date:  2015-10-02       Impact factor: 7.842

5.  Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.

Authors:  Jen-Chieh Lee; Yung-Ming Jeng; Jau-Yu Liau; Jia-Huei Tsai; Hung-Han Hsu; Ching-Yao Yang
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

6.  Telomerase-independent paths to immortality in predictable cancer subtypes.

Authors:  Stephen T Durant
Journal:  J Cancer       Date:  2012-01-31       Impact factor: 4.207

7.  The genetics of osteosarcoma.

Authors:  Jeff W Martin; Jeremy A Squire; Maria Zielenska
Journal:  Sarcoma       Date:  2012-05-20

8.  Genetic variation exists for telomeric array organization within and among the genomes of normal, immortalized, and transformed chicken systems.

Authors:  Thomas H O'Hare; Mary E Delany
Journal:  Chromosome Res       Date:  2009-11-05       Impact factor: 5.239

9.  HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes.

Authors:  Jonathan Miller; Aleksandra Dakic; Renxiang Chen; Nancy Palechor-Ceron; Yuhai Dai; Bhaskar Kallakury; Richard Schlegel; Xuefeng Liu
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

Review 10.  PML body meets telomere: the beginning of an ALTernate ending?

Authors:  Inn Chung; Sarah Osterwald; Katharina I Deeg; Karsten Rippe
Journal:  Nucleus       Date:  2012-05-01       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.